IVF Outcomes study: Photobiomodulation
Official title HELIOS Advanced: Human Embryo Illumination to Enhance Development
ClinicalTrials.gov ID: NCT07425080
What this study is testing
- What it's testing
- This study is testing whether adding a gentle red light treatment during IVF can improve how embryos grow and lead to better pregnancy results.
- Who it's for
- You may be able to join if you are a woman who is having IVF and are older or have had trouble with egg quality.
- What's involved
- You would receive a special red light treatment while your eggs are being fertilized in the lab. You will have your usual IVF visits and tests, but no extra medication or procedures.
- Time commitment
- The study lasts only the time of your IVF cycle, with a few extra visits for follow‑up after the cycle.
Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 48, women only. Healthy volunteers may be eligible.
You may be able to join if
- Female age between 18-48 years at the time of the IVF/ICSI cycle
- Undergoing blastocyst culture
- Using own oocytes
- Has at least two cleavage stage embryos available for randomization on Day 3 of embryo development
- Consenting to embryo level randomization
You likely can't join if
- Use of donor oocytes or gestational carrier
- Concurrent experimental laboratory inventions outside of protocol
- Refusal of randomization or request for non-standard handling
See the full eligibility criteria
- Female age between 18-48 years at the time of the IVF/ICSI cycle
- Undergoing blastocyst culture
- Using own oocytes
- Has at least two cleavage stage embryos available for randomization on Day 3 of embryo development
- Consenting to embryo level randomization
- Plan to transfer euploid embryo within 6 months
- Use of donor oocytes or gestational carrier
- Concurrent experimental laboratory inventions outside of protocol
- Refusal of randomization or request for non-standard handling
The study team makes the final eligibility decision.
Where it is enrolling
- New York, New York, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling female, 18 years to 48 years. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
This study is enrolling now at New York, New York, United States. Enter your location above to see the nearest enrolling site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.